NitroSynapsin, A Potential New Autism Drug, Reveals Scientific Breakthrough When Tested On Mice With MHS

Scientists at the Scintillon Institute, University of California, San Diego School of Medicine, and Sanford Burnham Prebys Medical Discovery Institute are combining their expertise to test the effects of a new autism drug, NitroSynapsin. Spearheaded by Dr. Stuart Lipton, NitroSynapsin, an aminoadamantane nitrate compound, intends to “restore an electrical signaling

Read the full article at the original source

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.